Idexx Laboratories, Inc (NASDAQ: IDXX) flaunted slowness of -1.40% at $755.96, as the Stock market unbolted on Wednesday, before settling in for the price of $766.68 at the close. Taking a more long-term approach, IDXX posted a 52-week range of $356.14-$769.24.
In the past 5-years timespan, the Healthcare sector firm’s annual sales growth was 16.90%. Meanwhile, its Annual Earning per share during the time was 16.90%. Nevertheless, stock’s Earnings Per Share (EPS) this year is 21.16%. This publicly-traded company’s shares outstanding now amounts to $80.00 million, simultaneously with a float of $78.97 million. The organization now has a market capitalization sitting at $60.36 billion. At the time of writing, stock’s 50-day Moving Average stood at $663.01, while the 200-day Moving Average is $551.08.
Idexx Laboratories, Inc (IDXX) Ownership Facts and Figures
Sometimes it is also beneficial to study the sentiment of large-scale investors towards the stock of the Idexx Laboratories, Inc industry. Idexx Laboratories, Inc’s current insider ownership accounts for 1.11%, in contrast to 92.81% institutional ownership. According to the most recent insider trade that took place on Nov 07 ’25, this organization’s Executive Vice President sold 9,425 shares at the rate of 703.34, making the entire transaction reach 6,629,014 in total value, affecting insider ownership by 21,149.
Idexx Laboratories, Inc (IDXX) Earnings and Revenue Records
Idexx Laboratories, Inc’s EPS increase for this current 12-month fiscal period is 21.16% and is forecasted to reach 14.45 in the upcoming year. Considering the longer run, market analysts have predicted that Company’s EPS will increase by 15.49% through the next 5 years, which can be compared against the 16.90% growth it accomplished over the previous five years trading on the market.
Idexx Laboratories, Inc (NASDAQ: IDXX) Trading Performance Indicators
Let’s observe the current performance indicators for Idexx Laboratories, Inc (IDXX). It’s Quick Ratio in the last reported quarter now stands at 0.81. Alongside those numbers, its PE Ratio stands at $59.93, and its Beta score is 1.64. Another valuable indicator worth pondering is a publicly-traded company’s price to sales ratio for trailing twelve months, which is currently 14.48. Similarly, its price to free cash flow for trailing twelve months is now 62.65.
In the same vein, IDXX’s Diluted EPS (Earnings per Share) trailing twelve months is recorded 12.61, a figure that is expected to reach 2.93 in the next quarter, and analysts are predicting that it will be 14.45 at the market close of one year from today.
Technical Analysis of Idexx Laboratories, Inc (IDXX)
Now, what If we examine the latest scores posted by [Idexx Laboratories, Inc, IDXX]. During the last 5-days, its volume was better the volume of 0.66 million it reported in year-ago period. During the previous 9 days, stock’s Stochastic %D was recorded 92.17% While, its Average True Range was 69.86.
Raw Stochastic average of Idexx Laboratories, Inc (IDXX) in the period of the previous 100 days is set at 94.67%, which indicates a major rise in contrast to 86.61% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 21.13 that was higher than 15.57 volatility it exhibited in the past 100-days period.
